Impact of Pacemaker Implantation on Long-Term Survival After Mitral Valve Surgery

Jessica K Millar1, Callie VanWinkle2, Catherine Wagner3

  • 1Department of Surgery, University of Michigan, Ann Arbor, Michigan; Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan.

PubMed
Abstract

Insights

Permanent pacemaker implantation (PPM) after mitral valve surgery (MVS) is not independently linked to worse long-term survival. Patients needing PPM have higher baseline risk, highlighting the need for proactive perioperative planning.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Devices

Background:

  • Conduction disorders after aortic valve surgery requiring permanent pacemaker implantation (PPM) are linked to reduced survival.
  • Data on PPM after mitral valve surgery (MVS) are limited, necessitating further investigation.

Purpose of the Study:

  • To evaluate the impact of new PPM on long-term survival after MVS.
  • To assess resource utilization, including ICU length of stay and 30-day readmission rates.

Main Methods:

  • A retrospective analysis of patients undergoing MVS from 2000-2022.
  • Stratification based on the need for postoperative PPM.
  • Kaplan-Meier analysis and Cox proportional hazard models to assess survival outcomes.

Main Results:

  • Of 4690 MVS patients, 5.2% required PPM and had more preoperative risk factors.
  • PPM patients experienced longer ICU stays and higher readmission rates.
  • While initially associated with decreased survival, PPM was not an independent predictor of worse long-term survival after adjustment.

Conclusions:

  • PPM after MVS is not independently associated with diminished long-term survival.
  • Patients requiring PPM exhibit a worse baseline clinical status.
  • Identifying at-risk patients for PPM is crucial for optimizing perioperative planning, resource use, and survival outcomes.

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
48
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
29
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
41
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
51
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
35
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
53